Actively Recruiting
Searching Biomarkers of Acute Intestinal Ischemic Injuries
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-12-16
556
Participants Needed
1
Research Sites
506 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the SURVIBIO study is to characterize accurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based on the analysis of human biological samples from patients and controls that will be conserved in a biological library. Samples will be analysed in the Laboratory for Vascular Translational Sciences (LVTS, Inserm U1148), in the Department of Biochemistry (Pr Puy, Dr Peoc'h), in Paris V university , in Imperial College of London (Pr Dumas), in Jacques Monod Institute and in Maastricht University Medical Center . The candidate markers will be determined according to an a priori method (form markers already described in the literature) and with no a priori strategy using -omics methods.
CONDITIONS
Official Title
Searching Biomarkers of Acute Intestinal Ischemic Injuries
Who Can Participate
Eligibility Criteria
You may qualify if you...
- age> 18 years
- Acute abdominal pain requiring an injected abdominal injected CT scan, at best at non-injected / early arterial / portal time
- Admitted or attended in Beaujon and / or Bichat hospitals
- Patient covered by a social security scheme
- Written consent
You will not qualify if you...
• lack of abdominal CT scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Corcos Olivier
Clichy, France
Actively Recruiting
Research Team
O
olivier corcos
CONTACT
A
Alexandre Nuzzo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here